Software is driving a paradigm shift in the healthcare continuum by bringing a single platform to market where laboratories, healthcare providers, physicians, patients, independent software vendors and app developers can work in synchrony to democratize pharmacogenomics.
Hausheer's rich experience in global oncology clinical drug development and translational
science and medicine makes him ideally suited to taking this role.
Software is building an ecosystem of laboratories, health professionals, independent software vendors, and employers to coordinate and deliver comprehensive, personalized care.Translational Software can help employers understand and deliver an evidence-based pharmacogenomic benefit to their associates through custom programs like this one.
science takes observations made in the laboratory, clinic and community and creates interventions that improve the health of individuals and populations from diagnostics and therapeutics to medical procedures and behavioral interventions.
Establishing a shared understanding and common vocabulary for discussing translational
research in the environmental health sciences context supports our strategic plan and provides a structure for researchers to clearly articulate the complex, multiyear process of scientific discovery and impacts.
Research themes being pursued in Clinical and Translational
Imaging lab seamlessly gel with the multidisciplinary courses being offered at LUMS and provide a unique set of applications to the tools learned in these courses which remain elusive in Pakistan.
medicine approaches in drug discovery & development
As we will see, in psychiatry, "translational
research" is used in different ways that only partially overlap with the medical usage, so a different list of "T" types will emerge.
In 2013, the Institute of Medicine's CTS Report focused on NIH's National Center for Advancing Translational
Science (NCATS) funded programs and provided goals that most academic institutions should adopt to improve health.
Rising awareness among people regarding regenerative medicines, increasing government initiative across the globe and growing aging population & healthcare expenditure are considered to be the key factors driving the growth of global translational
regenerative medicine market.
A simplified model of translational
research consists of a two stage approach (T1 and T2).
Funded by the National Institute on Aging, TRIPLL joins researchers at Human Ecology and the Bronfenbrenner Center for Translational
Research with collaborators at Weill Cornell and at NYC-based health care facilities and agencies.